Transcriptional regulation of vav, a gene expressed throughout the hematopoietic compartment

Blood

Volumn 91, Issue 2, 1998, Pages 419-430

  Ogilvy, Sarah ^a   Elefanty, Andrew G ^a   Visvader, Jane ^a   Bath, Mary L ^a   Harris, Alan W ^a   Adams, Jerry M ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL SPECIFICITY; CONTROLLED STUDY; FIBROBLAST; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; T LYMPHOCYTE; TRANSCRIPTION REGULATION;

EID: 0031962758     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.2.419     Document Type: Article

References (46)

1. Katzav S, Martin Zanca D, Barbacid M: vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. EMBO J 8:2283, 1989
2. Adams JM, Houston H, Allen J, Lints T, Harvey R: The hematopoietically expressed vav proto-oncogene shares homology with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organisation. Oncogene 7:611, 1992
3. Bonnefoy-Bérard N, Munshi A, Yron I, Wu S, Collins TL, Deckert M, Shalom-Barak T, Giampa L, Herbert E, Hernandez J, Meller N, Couture C, Altman A: Vav: Function and regulation in hematopoietic cell signaling. Stem Cells 14:250, 1996
4. Crespo P, Schuebel KE, Ostrom AA, Gutkind JS, Bustelo XR: Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the Vav proto-oncogene product. Nature 585:169, 1997
5. Tarakhovsky A, Tumer M, Schaal S, Mee PJ,Duddy LP, Rajewsky K, Tybulewicz VLJ: Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature 374:467, 1995
6. Zhang R, Alt FW, Davidson L, Orkin SH, Swat W: Defective signalling through the T-and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature 374:470, 1995
7. + thymocytes. Nature 374:474, 1995
8. Zmuidzinas A, Fischer K-D, Lira SA, Forrester L, Bryant S, Bernstein A, Barbacid M: The vav proto-oncogene is required early in embryogenesis but not for hematopoietic development in vitro. EMBO J 14:1, 1995
9. Coppola J, Bryant S, Koda T, Conway D, Barbacid M: Mechanism of activation of the vav protooncogene. Cell Growth Differ 2:95, 1991
10. Bustelo XR, Rubin SD, Suen K-L, Carrasco D, Barbacid M: Developmental expression of the vav protooncogene. Cell Growth Differ 4:297, 1993
11. Keller G, Kennedy M, Papayannopoulou T, Wiles MV: Hematopoietic commitment during embryonic stem cell differentiation in culture. Mol Cell Biol 13:473, 1993
12. Okumura K, Kaneko Y, Nonoguchi K, Nishiyama H, Yokoi H, Higuchi T, Itoh K, Yoshida O, Miki T, Fujita J: Expression of a novel isoform of vav, vav-t, containing a single SRC homology 3 domain in murine testicular germ cells. Oncogene 14:713, 1997
13. Gross DS, Garrard WT: Nuclease hypersensitive sites in chromatin. Annu Rev Biochem 57:159, 1988
14. Grosveld F, van Assendelft GB, Greaves DR, Kollias G: Position-independent, high-level expression of the human β-globin gene in transgenic mice. Cell 51:975, 1987
15. Dillon N, Grosveld F: Transcriptional regulation of multigene loci: Multilevel control. Trends Genet 9:134, 1993
16. Walters MC, Fiering S, Eidemiller J, Magis W, Groudine M, Martin DI: Enhancers increase the probability but not the level of gene expression. Proc Natl Acad Sci USA 92:7125, 1995
17. Walters MC, Magis W, Fiering S, Eidemiller J, Scalzo D, Groudine M, Martin DIK: Transcriptional enhancers act in cis to suppress position-effect variegation. Genes Dev 10:185, 1996
18. Martin DIK, Whitelaw E: The vagaries of variegating transgenes. Bioessays 18:919, 1996
19. Nolan GP, Fiering S, Nicholas F, Herzenberg LA: Fluorescence-activated cell analysis and sorting of viable mammalian cells based on β-D-galactosidase activity after transduction of Escherichia coli lacZ. Proc Natl Acad Sci USA 85:2603, 1988
20. Roederer M, Fiering S, Herzenberg LA: FACS-gal: Flow cytometric analysis and sorting of cells expressing reporter gene constructs. METHODS: A Companion to Methods Enzymol 2:248, 1991
21. Severne Y, Wieland S, Schaffner W, Rusconi S: Metal binding "finger" structures in the glucocorticoid receptor defined by site-directed mutagenesis. EMBO J 7:2503, 1988
22. Takebe Y, Seiki M, Fujisawa J-I, Hoy P, Yokota K, Arai K-I, Yoshida M, Arai N: SRα promoter: An efficient and versatile mammalian cDNA expression system composed of the Simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol Cell Biol 8:466, 1988
23. MacGregor GR, Nolan GP, Fiering S, Roederer M, Herzenberg LA: Use of E.coli lacZ (β-galactosidase) as a reporter gene, in Murray E (eds): Gene Transfer and Expression Protocols. Clifton, NJ, Humana, 1991, p 217
24. de Wet JR, Wood KV, DeLuca M, Helinski DR, Subramani S: Firefly luciferase gene: Structure and expression in mammalian cells. Mol Cell Biol 7:725, 1987
25. Hogan B, Beddington R, Costantini F, Lacy E: Manipulating the Mouse Embryo (ed 2). Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1994
26. Zambrowicz BP, Imamoto A, Fiering S, Herzenberg LA, Kerr WG, Soriano P: Disruption of Overlapping transcripts in the ROSA βgeo 26 gene trap strain leads to widespread expression of β-galactosidase in mouse embryos and hematopoietic cells. Proc Natl Acad Sci USA 94:3789, 1997
27. Strasser A, Harris AW, Cory S: Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67:889, 1991
28. Unkeless JC: Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med 150:580, 1979
29. Shortman K, Williams N, Adams P: The separation of different cell classes from lymphoid organs V. Simple procedures for the removal of cell debris, damaged cells and erythroid cells from lymphoid cell suspensions. J Immunol Methods 1:273, 1972
30. Katzav S, Cleveland JL, Heslo HE, Pulido D: Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential. Mol Cell Biol 11:1912, 1991
31. Edwards JBDM, Delort J, Mallet J: Oligodeoxyribonucleotide ligation to single-stranded cDNAs: A new tool for cloning 5′ ends of mRNAs and for constructing cDNA libraries by in vitro amplification. Nucleic Acids Res 19:5227, 1991
32. Ernst P, Smale ST: Combinatorial regulation of transcription I: General aspects of transcriptional control. Immunity 2:311, 1995
33. May G, Enver T: Targeting gene expression to haemopoietic stem cells: A chromatin-dependent upstream element mediates cell type-specific expression of the stem cell antigen CD34. EMBO J 14:564, 1995
34. Dobie K, Mehtali M, McClenaghan M, Lathe R: Variegated gene expression in mice. Trends Genet 13:127, 1997
35. Robertson G, Garrick D, Wilson M, Martin DIK, Whitelaw E: Age-dependent silencing of globin transgenes in the mouse. Nucleic Acids Res 24:1465, 1996
36. Milot E, Strouboulis J, Trimborn T, Wijgerde M, de Boer E, Langeveld A, Tan-Un K, Vergeer W, Yannoutsos N, Grosveld F, Fraser P: Heterochromatin effects on the frequency and duration of LCR-mediated gene transcription. Cell 87:105, 1996
37. Guy L-G, Kothary R, De Repentigny Y, Delvoye N, Ellis J, Wall L: The β-globin locus control region enhances transcription of but does not confer position-independent expression onto the lacZ gene in transgenic mice. EMBO J 15:3713, 1996
38. Sutherland HGE, Martin DIK, Whitelaw E: A globin enhancer acts by increasing the proportion of erythrocytes expressing a linked transgene. Mol Cell Biol 17:1607, 1997
39. Festenstein R, Tolaini M, Corbella P, Mamalaki C, Parrington J, Fox M, Miliou A, Jones M, Kioussis D: Locus control region function and heterochromatin-induced position effect variegation. Science 271: 1123, 1996
40. Robertson G, Garrick D, Wu W, Kearns M, Martin D, Whitelaw E: Position-dependent variegation of globin transgene expression in mice. Proc Natl Acad Sci USA 92:5371, 1995
41. Dorer DR, Henikoff S: Expansions of transgene repeats cause heterochromatin formation and gene silencing in Drosophila. Cell 77:993, 1994
42. Ravid K, Beeler DL, Rabin MS, Ruley HE, Rosenberg RD: Selective targeting of gene products with the megakaryocyte platelet factor 4 promoter. Proc Natl Acad Sci USA 88:1521, 1991
43. Pondel MD, Proudfoot NJ, Whitelaw C, Whitelaw E: The developmental regulation of the human ζ-globin gene in transgenic mice employing β-galactosidase as a reporter gene. Nucleic Acids Res 20:5655, 1992
44. Kerr WG, Herzenberg LA: Gene-search viruses and FACS-gal permit the detection, isolation, and characterization of mammalian cells with in situ fusions between cellular genes and Escherichia coli lacZ. METHODS: A Companion to Methods Enzymol 2:261, 1991
45. Dziennis S, Van Etten RA, Pahl HL, Morris DL, Rothstein TL, Blosch CM, Perlmutter RM, Tenen DG: The CD11b promoter directs high-level expression of reporter genes in macrophages in transgenic mice. Blood 85:319, 1995
46. Cui C, Wani MA, Wight D, Kopchick J, Stambrook PJ: Reporter genes in transgenic mice. Transgenic Res 3:182, 1994